Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News AHA 2016

Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients

Yael L. Maxwell

November 13, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Daily News

EUCLID: Ticagrelor Holds No Edge Over Clopidogrel for Preventing Atherothrombotic Events in Symptomatic PAD Patients

Shelley Wood

October 07, 2016

News Daily News

Ensayo EUCLID: Ticagrelor No es Más Beneficioso que Clopidogrel en la Prevención de Episodios CV en Pacientes con EAP Sintomática

Shelley Wood

October 07, 2016

News Conference News ESC 2016

Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy

Todd Neale

September 02, 2016

News Industry News

Symic Biomedical Selects Vascular Clinical Candidate

July 20, 2015

News Daily News

El Tratamiento Antiplaquetario Doble se asoció a Mejores Resultados en Pacientes EAP de Alto Riesgo

Leah Lawrence

April 29, 2015

News Daily News

Dual Antiplatelet Therapy Tied to Better Outcomes in High Risk PAD Patients

Leah Lawrence

April 29, 2015

News Daily News

Risk Score for Critical Limb Ischemia Identifies Patients with Poor Prognosis

December 29, 2014

News Daily News

La Alta Reactividad Plaquetaria se asocia a Más Episodios Adversos tras Intervenciones Endovasculares

Yael L. Maxwell

April 26, 2013

News Daily News

High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures

Yael L. Maxwell

April 26, 2013

Presentation

Platelet Responsiveness to Clopidogrel Treatment After Peripheral Endovascular Procedures

Presenter: Stavros Spiliopoulos

April 25, 2013

News Daily News

Even When It Fails, Endovascular Therapy Better First-Line Treatment than Surgery for Aortoiliac Disease

L.A. McKeown

September 19, 2012

News Daily News

Aún Cuando Fracasa, la Terapia Endovascular es Mejor como Tratamiento de 1ª Línea que la Cirugía contra la Enfermedad Aortoilíaca

L.A. McKeown

September 19, 2012

News Daily News

Single-Center Studies Build Case for Venous Angioplasty in Multiple Sclerosis

Caitlin E. Cox

April 05, 2012

News Daily News

Estudios de un Único Centro Exponen sus Argumentos en Favor de la Angioplastia Venosa en Pacientes con Esclerosis Múltiple

Caitlin E. Cox

April 05, 2012

Advertisement

Ticagrelor Fails to Best Clopidogrel in Preventing CV Events in PAD Patients

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

EUCLID: Ticagrelor Holds No Edge Over Clopidogrel for Preventing Atherothrombotic Events in Symptomatic PAD Patients

Ensayo EUCLID: Ticagrelor No es Más Beneficioso que Clopidogrel en la Prevención de Episodios CV en Pacientes con EAP Sintomática

Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy

Symic Biomedical Selects Vascular Clinical Candidate

El Tratamiento Antiplaquetario Doble se asoció a Mejores Resultados en Pacientes EAP de Alto Riesgo

Dual Antiplatelet Therapy Tied to Better Outcomes in High Risk PAD Patients

Risk Score for Critical Limb Ischemia Identifies Patients with Poor Prognosis

La Alta Reactividad Plaquetaria se asocia a Más Episodios Adversos tras Intervenciones Endovasculares

High Platelet Reactivity Linked to More Adverse Events After Endovascular Procedures

Platelet Responsiveness to Clopidogrel Treatment After Peripheral Endovascular Procedures

Even When It Fails, Endovascular Therapy Better First-Line Treatment than Surgery for Aortoiliac Disease

Aún Cuando Fracasa, la Terapia Endovascular es Mejor como Tratamiento de 1ª Línea que la Cirugía contra la Enfermedad Aortoilíaca

Single-Center Studies Build Case for Venous Angioplasty in Multiple Sclerosis

Estudios de un Único Centro Exponen sus Argumentos en Favor de la Angioplastia Venosa en Pacientes con Esclerosis Múltiple

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content